期刊文献+

慢性重型肝炎病原学、病变基础、性别、年龄分布与预后相关性的探讨 被引量:5

Correlation between the Etiology,Pathological Change Foundation,Sex,Age Distribution and Prognosis with Chronic Severe Hepatitis
在线阅读 下载PDF
导出
摘要 目的探讨慢性重型肝炎病原学、病变基础、性别、年龄分布与预后的相关性。方法回顾性总结慢性重型肝炎患者322例,分析其病原学特点、病变基础、性别、年龄分布及与预后的相关性,并进行统计学处理。结果(1)4种不同病原学模式患者的病死率间差别有显著性意义(P<0.05);(2)慢性乙型肝炎和肝硬化基础上发生的慢性重型肝炎的病死率间差异有显著性意义(P<0.05);(3)不同性别、不同发病年龄患者的病死率间差别有显著性意义(P<0.05);(4)单纯乙肝病毒感染与重叠感染患者的病死率间差别无显著性意义(P>0.05)。结论乙肝病毒呈复制状态、病变呈肝硬化基础、男性患者、年龄较大者发生慢性重型肝炎的预后不良。 Objective To study the etiology, pathological change foundation, sex, age distribution and prognosis of chronic severe hepatitis. Methods Retrospective summary of 322 cases of chronic severe hepatitis B was performed to analyze the correlativity of the disease in the etiology characteristic, pathological change foundation, sex, age distribution with the prognosis. SPSS11.5 software Was used in statistical processing. Results There was a remarkable difference in mortality rate among the four etiological models of the hepatitis B virus infection ( P 〈0. 05 ). There was a remarkable difference in mortality rate between chronic hepatitis and chronic severe hepatitis based on liver cirrhosis ( P 〈0.05). There was a significant difference in mortality rate among the populations of different sexes and different age distributions ( P 〈 0. 05). While there was no significant difference in mortality rate between patients with simple hepatitis B virus infection and those with super - infection ( P 〉 0. 05). Conclusion The prognoses of chronic severe hepatitis are unfavorable in those patients whose hepatitis B virus assumes the duplication condition, whose pathological change has liver cirrhosis foundation, who is male, and whose age is higher.
出处 《中国全科医学》 CAS CSCD 2006年第19期1600-1601,共2页 Chinese General Practice
基金 北京市科委科技基金项目(H020920020890)
关键词 慢性重型肝炎 肝炎病毒 乙型 预后 Chronic severe hepatitis Hepatitis B virus Prognosis
作者简介 通讯作者:孟庆华,100069北京佑安医院肝病四科;E-mail:meng_qh@sohu.com。
  • 相关文献

参考文献8

二级参考文献9

  • 1Naruse K,Makuu chi M.Development and perspectives of bioartifical liver support[J].Hepatogastroenterology,2002,49:91-95.
  • 2Strain J,Neuberger M.A bioartifical liver -state of the art[J].Science,2002,295:1005.
  • 3Kelly JH,Koussayer T,He D,et al.Assessment of and extracorporeal liver assist device in anhepatic dogs[J].Artif Organs,1992,16:418.
  • 4Smirthwaite,Gaylor D,Cousins B,et al.Cytotoxicity of bile in human HepG2 cell and in primary cultures of rat hepatocytes[J].Artif Organs,1998,22:831-836.
  • 5Edward T.Regulation of cytochrome p450 by inflammatory mediators:why and how[J].Drug metabolism and disposition,2001,29(3):207.
  • 6McCloskey P,Tootle R,Selden C,et al.Modulation of Hepatocyte Function in an immortalized human hepatocyte cell line following exposure to liver failure plasma[J].Artif Organs,2002,26:340-348.
  • 7Hiromitsu N,Michiaki M,Makoto N,et al.Injuriousness of glycochenodeoxycholate and taurochenodeoxycholate to cultured hepatocytes[J].J Artif Organs,2002,5:30-36.
  • 8Yasutoshi Muto M.D.,Jun′ichi Sugihara,Hiroo Ohnishi,Hisataka Moriwaki,Kusuya Nishioka. Anti-hepatitis C virus antibody prevails in fulminant hepatic failure[J] 1990,Gastroenterologia Japonica(1):32~35
  • 9中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14021

共引文献14030

同被引文献45

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部